Superior Planning LLC’s Mineralys Therapeutics MLYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$779 Buy
+31
New +$844 ﹤0.01% 1808

Other funds holding MLYS

Superior Planning LLC's MLYS Position: Q3 2026 in Review

Superior Planning LLC opened a new position in Mineralys Therapeutics (MLYS) in Q3 2026: 31 shares worth $779. The stake represents ﹤0.01% of the portfolio and ranks #1808 among its holdings.

152 funds tracked by Wall St. Rank hold MLYS as of Q3 2026.

  • Superior Planning LLC held 31 shares of Mineralys Therapeutics worth $779 as of Q3 2026.
  • Mineralys Therapeutics was a new Superior Planning LLC position in Q3 2026.
  • Mineralys Therapeutics made up ﹤0.01% of Superior Planning LLC's portfolio in Q3 2026, its #1808 holding.
  • 152 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q3 2026.

Based on Superior Planning LLC's 13F filing for Q3 2026, filed 12 Nov 2026.